Abstract
Eyes treated with a topical betablocker may exhibit the phenomenon of longterm drift, leading to loss of intraocular pressure control. It has been suggested that discontinuation of the betablocker may restore sensitivity to betablocker therapy, and that this phenomenon might be enhanced by the administration of an adrenergic agonist during this holiday period. This study was set up to examine further this hypothesis. Nine patients with ocular hypertension receiving treatment with timolol were entered into the study. Timolol was discontinued then re-started after four weeks of treatment with dipivefrin. This treatment cycle was repeated after a further four weeks. IOP was measured every two weeks. Re-introduction of timolol was associated with a significant lowering of IOP at two weeks (3.2mmHg in the first cycle, p<0.01, 3.4 mmHg in the second cycle, p<0.01). Discontinuation of timolol and treatment with dipivefrin was not associated with a significant change in IOP.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Steinert RF, Thomas JV, Boger WP. Long-term drift and continued efficacy after multiyear timolol therapy. Arch Ophthalmol 1981; 99: 100–3.
Boger WP, Shortterm ‘sescape’ and longterm ‘drift’. The dissipation effects of the beta adrenergic blocking agents. Surv Ophthalmol 1983; 28: 235–40.
Schenker HI, Yablonski ME, Podos SM, Under L. Fluorophotometric study of epinephrine and timolol in human subjects. Arch Ophthalmol 1981; 99:1212–6.
Coakes RL, Brubaker RF. The mechanism of timolol in lowering intraocular pressure. Arch Ophthalmol 1978; 96: 2045–8.
Yablonski ME, Zimmerman TJ, Waltman SR, Becker B: A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics. Exp Eye Res 1978; 27: 135–42.
Townsend DJ, Brubaker RF. Immediate effect of epinephrine on aqueous formation in the normal human eye as measured by fluorophotometry. Invest Ophthalmol Vis Sci 1980; 19: 256–66.
Korey MS, Hodapp E, Kass MA, Goldberg I, Gordon M, Becker B. Timolol and epinephrine. Long-term evaluation of concurrent administration. Arch Ophthalmol 1982; 100: 742–5.
Thomas JV, Epstein DL. Timolol and epinephrine in primary open angle glaucoma. Transient additive effect. Arch Ophthalmol 1981; 99: 91–5.
Cyrlin MN, Thomas JV, Epstein DL. Additive effect of epinephrine to timolol therapy in primary open angle glaucoma. Arch Ophthalmol 1982; 100: 414–8.
Goldberg I, Ashburn FS, Palmberg PF, Kass MA, Becker B. Timolol and epinephrine. A clinical study of ocular interactions. Arch Ophthalmol 1980; 98: 484–6.
Keates EU, Stone RA. Safety and effectiveness of concomitant administration of dipivefrin and timolol maleate. Am J Ophthalmol 1981; 91: 243–8.
Sibley DR, Lefkowitz RJ. Molecular mechanisms of receptor desensitization using the beta-adrenergic receptor-coupled adenylate cyclase system as a model. Nature 1985; 317: 124–9.
Neufeld AH, Zawistowski KA, Page ED, Bromberg BB. Influences on the density of beta-adrenergic receptors in the cornea and iris-ciliary body of the rabbit. Invest Ophthalmol Vis Sci 1978; 17: 1069–75.
Mills KB. Blind randomised non-crossover long-term trial comparing topical timolol 0.25% with timolol 0.5% in the treatment of chronic simple glaucoma. Br J Ophthalmol 1983; 67: 216–9.
Gandolfi SA. Restoring sensitivity to timolol after long term drift in primary open angle glaucoma. Invest Ophthalmol Vis Sci 1990; 31: 354–8.
Campbell SH, Hickey-Dwyer M, Harding SP. Double masked three period crossover investigation of timolol in control of raised intraocular pressure. Eye 1992.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Batterbury, M., Harding, S.P. & Wong, D. Long-term drift and timolol therapy: possible role for pulsed therapy. Int Ophthalmol 16, 321–324 (1992). https://doi.org/10.1007/BF00917984
Issue Date:
DOI: https://doi.org/10.1007/BF00917984